Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velaglucerase alfa vs Imiglucerase in Type 1 Gaucher Disease
NCT00553631Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2008
- Primary completion
- May 2009
- Modality
- Replacement Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of velaglucerase alfa in Gaucher disease type 1 (GD1), sponsored by Takeda. Started Jan 2008; status: completed.
02
Drugs
velaglucerase alfa
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00553631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553631.